Literature DB >> 19772411

Combined endoscopic-microsurgical approach for transsphenoidal (sphenopalatine) encephalocele with an intralesional pituitary gland. Case report.

Roberto Faggin1, Luigi Pentimalli, Maurizia Grazzini, Roberto Saetti, Paola Drigo, Domenico d'Avella.   

Abstract

The treatment of the transsphenoidal sphenopalatine encephalocele in infants has not been thoroughly described in the literature. Pterional and subfrontal transbasal approaches have been reported as the advised treatment for transethmoidal encephalocele, but their feasibility for transsphenoidal encephalocele remains controversial, particularly in neonates. The potential harm to vital structures within the herniated tissue and intraoperative bleeding have been considered the major cause of poor postoperative results. The authors present the case of a full-term newborn with a cleft palate and a large transsphenoidal sphenopalatine encephalocele, which filled the nasopharyngeal space and provided MR imaging evidence of an intralesional pituitary gland. The lesion is unusual, and the extracranial intraoral endoscopic approach with an optimal outcome and sparing of the pituitary tissue has never been described in detail in an infant of this age.

Entities:  

Mesh:

Year:  2009        PMID: 19772411     DOI: 10.3171/2009.4.PEDS0884

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  2 in total

1.  Transsphenoidal encephalocele masquerading as nasal mass in a 2-year-old boy.

Authors:  Suresh Chandran; Shilpee Raturi; Haroon M Pillay; Teo Eu-leong Harvey James
Journal:  BMJ Case Rep       Date:  2014-03-12

2.  A hybrid simulation model for pre-operative planning of transsphenoidal encephalocele.

Authors:  Giselle Coelho; Nicollas Nunes Rabelo; Eduardo Varjão; Thailane Marie; Daniella Brito; Emilio C Del Massa; Henrique Zuppani; Belmiro Matos; Maurício Yoshida; João Paulo Mota Telles; Manoel Jacobsen Teixeira; Eberval Gadelha Figueiredo
Journal:  Neurosurg Rev       Date:  2020-08-08       Impact factor: 3.042

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.